CYTK
CYTK
NASDAQ · Biotechnology

Cytokinetics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$76.91
+2.62 (+3.53%)
As of May 9, 1:13 AM ET ·
Analyst Consensus
Strong Buy
27
Analysts
High
Coverage
Buy 23 85%
Hold 4 15%
Sell 0 0%
Price Target
Analyst Price Target +3.8% upside
Low Target $53.35
Average Target $79.81
High Target $115.71
Current Price $76.91
Current
$76.91
Target
$79.81
$53.35 $79.81 avg $115.71
Scenario Analysis
Bear Case
$53.35
-30.6%
Low target
Base Case
$79.81
+3.8%
Avg target
Bull Case
$115.71
+50.4%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$80.20
-4.1% from high
52-Week Low
$29.31
+162.4% from low
50-Day SMA
$63.59
+20.9% vs SMA
200-Day SMA
$49.97
+53.9% vs SMA
RSI (14)
55.5
Neutral
Target vs 52W High
$79.81
-0.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%